Global Contraceptive Drugs and Devices Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Contraceptive Drugs and Devices Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
A contraceptive is a device or drug that prevents a woman from becoming pregnant.
Contraceptive Drugs and Devices report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Contraceptive Drugs and Devices market is projected to reach US$ 8873.2 million in 2034, increasing from US$ 6531.7 million in 2022, with the CAGR of 4.4% during the period of 2024 to 2034. Demand from Hospitals and Pharmacies are the major drivers for the industry.
The key factors contributing to the contraceptive drugs and devices market are growing prevalence of sexually transmitted diseases and the growing need to control the rising population.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Contraceptive Drugs and Devices market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Bayer Healthcare
Merck
Church & Dwight
Warmer Chilcott
Agile Therapeutics
Pfizer
BioSante Pharmaceuticals
Mayer Laboratories
Pantarhei Bioscience
Teva Pharmaceutical Industries
Segment by Type
Oral
Vaginal
Injectable Contraceptive Drugs
Male/Female Contraceptive Devices
Hospitals
Pharmacies
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Contraceptive Drugs and Devices market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Contraceptive Drugs and Devices, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Contraceptive Drugs and Devices industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Contraceptive Drugs and Devices in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Contraceptive Drugs and Devices introduction, etc. Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Contraceptive Drugs and Devices market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Contraceptive Drugs and Devices report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Contraceptive Drugs and Devices market is projected to reach US$ 8873.2 million in 2034, increasing from US$ 6531.7 million in 2022, with the CAGR of 4.4% during the period of 2024 to 2034. Demand from Hospitals and Pharmacies are the major drivers for the industry.
The key factors contributing to the contraceptive drugs and devices market are growing prevalence of sexually transmitted diseases and the growing need to control the rising population.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Contraceptive Drugs and Devices market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Bayer Healthcare
Merck
Church & Dwight
Warmer Chilcott
Agile Therapeutics
Pfizer
BioSante Pharmaceuticals
Mayer Laboratories
Pantarhei Bioscience
Teva Pharmaceutical Industries
Segment by Type
Oral
Vaginal
Injectable Contraceptive Drugs
Male/Female Contraceptive Devices
Segment by Application
Hospitals
Pharmacies
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Contraceptive Drugs and Devices market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Contraceptive Drugs and Devices, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Contraceptive Drugs and Devices industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Contraceptive Drugs and Devices in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Contraceptive Drugs and Devices introduction, etc. Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Contraceptive Drugs and Devices market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.